Cargando…
To Tweet or Not to Tweet: A Longitudinal Analysis of Social Media Use by Global Diabetes Researchers
BACKGROUND: Engaging influential stakeholders in meaningful exchange is essential for pharmaceutical companies aiming to improve care. At a time where opportunities for face-to-face engagement are limited, the ability to interact, learn and generate actionable insights through digital channels such...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650740/ https://www.ncbi.nlm.nih.gov/pubmed/34874534 http://dx.doi.org/10.1007/s40290-021-00408-6 |
_version_ | 1784611263791235072 |
---|---|
author | Leigh, Simon Noble, Max E. Pearson, Frances E. Iremonger, James Williams, David T. |
author_facet | Leigh, Simon Noble, Max E. Pearson, Frances E. Iremonger, James Williams, David T. |
author_sort | Leigh, Simon |
collection | PubMed |
description | BACKGROUND: Engaging influential stakeholders in meaningful exchange is essential for pharmaceutical companies aiming to improve care. At a time where opportunities for face-to-face engagement are limited, the ability to interact, learn and generate actionable insights through digital channels such as Twitter, is of considerable value. AIM: The aim of this study was to evaluate digital engagement among global diabetes mellitus researchers. MATERIALS AND METHODS: We identified every global tweet (20,614,515) and scientific publication (44,135) regarding diabetes mellitus from 1 August 2018 to 1 August 2020. Through author matching we combined datasets, resulting in a list of digitally active scientific authors. Generalised linear modelling identified factors predicting their digital engagement. FINDINGS: Globally, 2686 diabetes researchers used Twitter to discuss the management of diabetes mellitus, posting 110,346 diabetes-related tweets. As Twitter followers increased, so did tweet frequency (p < 0.001), retweets (p < 0.001) and replies (p < 0.001) to their content. Publication count (overall/per month) and proportion of first/last authorships were unrelated to tweet frequency and the likelihood of being retweeted or replied to (p > 0.05). Those with the most academic co-authors were significantly less likely to tweet than those with smaller networks (< 50; p = 0.001). Finally, those publishing most frequently on specific themes, including insulin (p = 0.041) and paediatrics (p < 0.001), were significantly more likely to tweet about these themes. CONCLUSION: Academic expertise and seniority cannot be assumed as proxies for digital influence. Those aiming to promote science and obtain digital insights regarding condition management should consider looking beyond well-known ‘key opinion leaders’ to perhaps lesser known ‘digital opinion leaders’ with smaller academic networks, who are likely to specialise in the delivery of highly specific content to captive audiences. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40290-021-00408-6. |
format | Online Article Text |
id | pubmed-8650740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-86507402021-12-07 To Tweet or Not to Tweet: A Longitudinal Analysis of Social Media Use by Global Diabetes Researchers Leigh, Simon Noble, Max E. Pearson, Frances E. Iremonger, James Williams, David T. Pharmaceut Med Original Research Article BACKGROUND: Engaging influential stakeholders in meaningful exchange is essential for pharmaceutical companies aiming to improve care. At a time where opportunities for face-to-face engagement are limited, the ability to interact, learn and generate actionable insights through digital channels such as Twitter, is of considerable value. AIM: The aim of this study was to evaluate digital engagement among global diabetes mellitus researchers. MATERIALS AND METHODS: We identified every global tweet (20,614,515) and scientific publication (44,135) regarding diabetes mellitus from 1 August 2018 to 1 August 2020. Through author matching we combined datasets, resulting in a list of digitally active scientific authors. Generalised linear modelling identified factors predicting their digital engagement. FINDINGS: Globally, 2686 diabetes researchers used Twitter to discuss the management of diabetes mellitus, posting 110,346 diabetes-related tweets. As Twitter followers increased, so did tweet frequency (p < 0.001), retweets (p < 0.001) and replies (p < 0.001) to their content. Publication count (overall/per month) and proportion of first/last authorships were unrelated to tweet frequency and the likelihood of being retweeted or replied to (p > 0.05). Those with the most academic co-authors were significantly less likely to tweet than those with smaller networks (< 50; p = 0.001). Finally, those publishing most frequently on specific themes, including insulin (p = 0.041) and paediatrics (p < 0.001), were significantly more likely to tweet about these themes. CONCLUSION: Academic expertise and seniority cannot be assumed as proxies for digital influence. Those aiming to promote science and obtain digital insights regarding condition management should consider looking beyond well-known ‘key opinion leaders’ to perhaps lesser known ‘digital opinion leaders’ with smaller academic networks, who are likely to specialise in the delivery of highly specific content to captive audiences. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40290-021-00408-6. Springer International Publishing 2021-12-07 2021 /pmc/articles/PMC8650740/ /pubmed/34874534 http://dx.doi.org/10.1007/s40290-021-00408-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Article Leigh, Simon Noble, Max E. Pearson, Frances E. Iremonger, James Williams, David T. To Tweet or Not to Tweet: A Longitudinal Analysis of Social Media Use by Global Diabetes Researchers |
title | To Tweet or Not to Tweet: A Longitudinal Analysis of Social Media Use by Global Diabetes Researchers |
title_full | To Tweet or Not to Tweet: A Longitudinal Analysis of Social Media Use by Global Diabetes Researchers |
title_fullStr | To Tweet or Not to Tweet: A Longitudinal Analysis of Social Media Use by Global Diabetes Researchers |
title_full_unstemmed | To Tweet or Not to Tweet: A Longitudinal Analysis of Social Media Use by Global Diabetes Researchers |
title_short | To Tweet or Not to Tweet: A Longitudinal Analysis of Social Media Use by Global Diabetes Researchers |
title_sort | to tweet or not to tweet: a longitudinal analysis of social media use by global diabetes researchers |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650740/ https://www.ncbi.nlm.nih.gov/pubmed/34874534 http://dx.doi.org/10.1007/s40290-021-00408-6 |
work_keys_str_mv | AT leighsimon totweetornottotweetalongitudinalanalysisofsocialmediausebyglobaldiabetesresearchers AT noblemaxe totweetornottotweetalongitudinalanalysisofsocialmediausebyglobaldiabetesresearchers AT pearsonfrancese totweetornottotweetalongitudinalanalysisofsocialmediausebyglobaldiabetesresearchers AT iremongerjames totweetornottotweetalongitudinalanalysisofsocialmediausebyglobaldiabetesresearchers AT williamsdavidt totweetornottotweetalongitudinalanalysisofsocialmediausebyglobaldiabetesresearchers |